Marine n-3 PUFA protects hearts from I/R injury via restoration of mitochondrial function

Scand Cardiovasc J. 2015;49(5):264-9. doi: 10.3109/14017431.2015.1071873.

Abstract

Objectives: Overwhelming evidence shows that dietary supplementation with n-3 polyunsaturated fatty acids (PUFAs) elicits protective effects on patients with cardiovascular disease. However, the detailed mechanisms underlying n-3 PUFA-mediated cardioprotection are unknown, and examined in the present study.

Methods: We evaluated heart performances with Langendorff perfusion apparatus. Meanwhile, whole mitochondria were purified from non-perfused hearts for functional assessment, and lipid peroxidation level was measured as well.

Results: Compared with control groups, hearts from n-3 PUFA-supplemented rats showed improved functional recovery and reduced tissue injury following ischemia/reperfusion (I/R). Furthermore, the mitochondrial function of PUFA-treated hearts was significantly enhanced, as demonstrated by biochemical analysis of respiratory chain activity. In addition, thiobarbituric acid-reactive substance or TBARS assay revealed that lipid peroxidation product, malondialdehyde or MDA, in the mitochondria was significantly reduced by PUFA treatment.

Conclusion: Taken together, our data indicate that marine n-3 PUFA could improve cardiac performance after I/R injury by restoring mitochondrial respiratory activities and attenuating lipid peroxidation.

MeSH terms

  • Animals
  • Disease Models, Animal
  • Drug Evaluation, Preclinical
  • Fatty Acids, Omega-3 / pharmacology
  • Fatty Acids, Omega-3 / therapeutic use*
  • Fish Oils / pharmacology
  • Fish Oils / therapeutic use*
  • In Vitro Techniques
  • Lipid Peroxidation / drug effects*
  • Male
  • Mitochondria, Heart / drug effects*
  • Myocardial Contraction / drug effects
  • Myocardial Reperfusion Injury / prevention & control*
  • Rats, Sprague-Dawley

Substances

  • Fatty Acids, Omega-3
  • Fish Oils